NCT02065011Active, not recruitingPhase 2
A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B
An Open-label Study to Determine the Long-term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
Primary Objective: To evaluate the long-term safety and tolerability of SAR421869 in patients with Usher syndrome Type 1B Secondary Objective: To assess long-term safety and biological activity of SAR421869
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- First submitted
- 14 Feb 2014
- Start date
- 12 Sept 2013
- Primary completion date
- 13 Jun 2031
- Lead sponsor
- Sanofi
- NCT number
- NCT02065011
- EudraCT number
- 2013-000597-29
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 9
- From 12 Sept 2013 to the primary completion date, 13 Jun 2031
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Did not receive SAR421869 as part of the TDU13600 protocol.
Who the study is looking for
- Provide signed and dated written informed consent (and if appropriate assent) and any locally required authorization eg, Health Insurance Portability and Accountability Act (HIPAA).
- Must have been enrolled in protocol TDU13600. Must have received a subretinal injection of SAR421869
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Investigational Site Number : 250001 Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Oregon Health and Science University Site Number : 840001 Coordinator of this site? Confirm its status | Portland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.